Stockreport

WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE [Canadian Business Journal (Canada)]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF VANCOUVER, British Columbia, March 13, 2020 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. Company GBM In the Phase 1 trial, 44% of patients experienced a statistically sig [Read more]